Authors
Latest:
Hepatitis C TreatmentThere are now 8 FDA approved medications for HCV treatment, all of which bypass the use of interferon.
Latest:
Using Technology for Patient Engagement: Are We There Yet?New tools and platforms can help pharmacists to support patients.
Latest:
The 340B Drug Pricing Program: Keeping Up with ChangesHealth-system pharmacists need to stay abreast of changes.
Latest:
Commentary: Specialty Pharmacy Helps Promote Patient AdherenceSuccessful outcomes with specialty pharmaceuticals depend on patient adherence—pharmacists play a vital role in educating patients prior to and during therapy.
Latest:
States Continue to Expand Availability of TelehealthTelehealth has become a viable niche in US health care because it lets patients and providers use technology to seek medical advice and diagnose and treat illnesses.
Latest:
Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing FacilitiesAlthough the federal government has taken steps to comprehensively regulate outsourcing facilities, many states have been slow to reform their pharmacy laws.
Latest:
Impact of Medicaid Preferred Drug List on Long-Acting Opioid UsersAn opioid preferred drug list was not associated with an increase in emergency department visits or hospitalizations in a Medicaid population.
Latest:
Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare ResourcesThis study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Latest:
Persistence With Mirabegron Versus Tolterodine in Patients With Overactive BladderIn a retrospective analysis of the Optum database, overactive bladder patients treated with mirabegron bladder patients persisted longer with treatment than patients treated with tolterodine, and had reduced resource utilization and costs.
Latest:
Cost Outcomes of Diabetes Education in a Specialized Community PharmacyDiabetes management offered by an employer group in a self-funded health plan over 3 years resulted in significant cost savings and improved patient outcomes.
Latest:
Telepharmacy Offers Opportunity Amid PandemicThe contributions to patient care through the incorporation of digital clinical pharmacotherapy will help legitimize the role of pharmacists in telehealth.
Latest:
The Expanding Health Benefits of Prebiotics and ProbioticsA Continuing Education program, featured in the February 2018 issue of Pharmacy Times.
Latest:
COPD Medication Adherence and Persistence Among Managed Medicare EnrolleesThe authors evaluated the significance of Medicare prescription plan choice on chronic obstructive pulmonary disease maintenance medication adherence and persistence using Optum Research Database information.
Latest:
New Antibiotics Treat Select Resistant InfectionsCefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.
Latest:
What Makes a Good Call Center for Patient Assistance Program Success?Effective specialty pharmacy patient assistance programs help patients access and remain adherent to high cost drugs.
Latest:
Implementing a Health-System Specialty PharmacyBy establishing in-house specialty pharmacies, health systems can accelerate growth while offering patients innovative therapies, an enhanced experience, and clinically coordinated care that ultimately improves outcomes.
Latest:
Hypertension: Promoting Adherence When a Condition Is "Silent"Educating patients about lifestyle changes, strict medication adherence, and home blood pressure monitoring can help them to avert complications from this often silent condition.
Latest:
FDA Adds Novel Antimicrobials to ArsenalAntimicrobial resistance continues to pose a significant health threat, necessitating new antibiotics with novel mechanisms to treat these complicated infections. However, between 2010 and 2018, newly approved antibiotics were primarily derived from previously established drug classes. This past summer, the FDA approved 2 new antibiotics.
Latest:
Pharmacists Can Help Assess New FDA-Approved IV OpioidOliceridine (Olinvyk) expands options for managing moderate to severe acute pain, but cost, drug-drug interactions, and other factors come into play.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
Specialty Pharmacy Improves Adherence to ImatinibThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
Worlds Apart: Health Care and Pharmacy in ChinaMy encounter with the Chinese health care system revealed practices very different from the ones in the United States.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Latest:
The Role of Specialty Pharmacies in Accountable Care OrganizationsWith their focus on data, reporting, and outcomes measurement, specialty pharmacies are uniquely positioned to play an important role in the changing health care landscape.
Latest:
Managing Medications for Elderly PatientsWith elderly patients being prescribed more drugs than ever before, caregivers face a huge challenge in managing medications and preventing negative outcomes.
